drugset / Trial / NCT01434888
Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops
RandomizedCrossoverTriple-blindBasic science
Summary
The objective of this study is to investigate the pharmacokinetics, safety and tolerability of the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% (FDC) to those of preservative-free tafluprost 0.0015% and timolol 0.5% eye drops in healthy volunteers.
Timeline
- Start
- 2011-09
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Preservative free FDC of tafluprost 0.0015% and timolol 0.5% eye drops | Unknown | 0.0015 % | Other |
| Subject | Preservative free FDC of tafluprost 0.0015% and timolol 0.5% eye drops | Unknown | 0.5 % | Other |
| Comparator | Tafluprost | Other / unclassified | 0.0015 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |
Indications
No indication recorded.